Sharecafe

Arovella Therapeutics (ASX: ALA) – Tackling blood cancers and solid tumours

Arovella Therapeutics Limited Managing Director and CEO Dr Michael Baker provides an update on what's been happening at the biotech company.

Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Dr Michael Baker provides an update on the company.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories